Byoungguk Kim
Overview
Explore the profile of Byoungguk Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hyun H, Nham E, Seong H, Yoon J, Noh J, Cheong H, et al.
Front Immunol
. 2024 May;
15:1385135.
PMID: 38756783
Background: The assessment of long-term humoral and cellular immunity post-vaccination is crucial for establishing an optimal vaccination strategy. Methods: This prospective cohort study evaluated adults (≥18 years) who received a...
2.
Lee B, Bae G, Jeong I, Kim J, Kwon M, Kim J, et al.
J Appl Lab Med
. 2024 Mar;
9(4):741-751.
PMID: 38531067
Background: Although age negatively correlates with vaccine-induced immune responses, whether the vaccine-induced neutralizing effect against variants of concern (VOCs) substantially differs across age remains relatively poorly explored. In addition, the...
3.
Choi M, Hyun H, Heo J, Seo Y, Noh J, Cheong H, et al.
Heliyon
. 2024 Mar;
10(5):e27211.
PMID: 38468934
Background: Data on the durability of booster dose immunity of COVID-19 vaccines are relatively limited. Methods: Immunogenicity was evaluated for up to 9-12 months after the third dose of vaccination...
4.
Yoon S, Park S, Lee J, Kim B, Gwak W
Int J Mol Sci
. 2024 Feb;
25(4).
PMID: 38397006
During the emergence of infectious diseases, evaluating the efficacy of newly developed vaccines requires antigen proteins. Available methods enhance antigen protein productivity; however, structural modifications may occur. Therefore, we aimed...
5.
Jeong I, Kim J, Kwon M, Kim J, Huh H, Kim B, et al.
J Korean Med Sci
. 2024 Feb;
39(5):e43.
PMID: 38317445
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally, leading to the coronavirus disease 2019 (COVID-19) pandemic. Because a significant proportion of the COVID-19 confirmed cases were concentrated...
6.
Choi M, Yu Y, Kim J, Ju H, Shin S, Yang Y, et al.
Clin Microbiol Infect
. 2024 Jan;
30(5):653-659.
PMID: 38253313
Objectives: Concomitant COVID-19 and influenza vaccination would be an efficient strategy. Although the co-administration of monovalent COVID-19 and influenza vaccinations showed acceptable immunogenicity, it remains unknown whether the bivalent COVID-19...
7.
Choi H, Achangwa C, Park J, Lee S, Lee N, Jeon C, et al.
Front Immunol
. 2024 Jan;
14:1306604.
PMID: 38193075
Background: Humoral immune responses and infection risk after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) vaccination during the Omicron BA.5 and BN.1 variants predominant...
8.
Lee B, Ko J, Kim Y, Baek J, Park Y, Song K, et al.
J Med Virol
. 2023 Dec;
95(12):e29329.
PMID: 38140877
Developing new antibody assays for emerging SARS-CoV-2 variants is challenging. SARS-CoV-2 surrogate virus neutralization tests (sVNT) targeting Omicron BA.1 and BA.5 have been devised, but their performance needs to be...
9.
Yang J, Kim H, Kim J, Baek J, Lee Y, Choi J, et al.
J Med Virol
. 2023 Dec;
95(12):e29285.
PMID: 38054545
Despite a high vaccination rate, the COVID-19 pandemic continues with immune-evading Omicron variants. The success of additional antigenic stimulation through breakthrough infection (BI) and updated vaccination in overcoming antigenic imprinting...
10.
Lee Y, Choi J, Yang J, Baek J, Kim H, Kim S, et al.
Microbiol Spectr
. 2023 Sep;
:e0165523.
PMID: 37750684
The coronavirus disease 2019 pandemic persisted for 3 years and is now transitioning to endemicity. We illustrated the change in group immunity induced by vaccination (monovalent vaccines) and breakthrough infections...